Intracranial tumours of childhood make up approximately 20% of the neoplastic conditions registered in those under 15 years of age, contrasting with the incidence in adults of 1-2% of all tumours. Over 200 cases occur each year in the United Kingdom, and they are distributed evenly through childhood years (Till 1975) . Again in contrast to adult tumours, children's tumours tend to arise in midline structures, the thalamus, brain stem and vermis cere belli, with as many as two-thirds of all cases being infratentorial in some series. It is frequently considered unwise to biopsy, let alone attempt excision, in these lesions. Therapeutic decisions and the interpretation of results may, therefore, be difficult.
Frequency of histological types also varies from the adult pattern. Meningiomas are rare in children as are pituitary adenomas. Brain metastases, very common in adults, are at present rare in children, but are likely to become more frequent with the increasingly successful treatment of primary tumours in other sites. The various gliomata occur in differing frequency also. The low-grade malignancy astrocytoma makes up a much higher proportion than in adults. Medulloblastomas make up 20% of intracranial tumours in children while oligodendrogliomata are very rare.
The classical triad of symptoms and signs of raised intracranial pressure is not so usual at the time of presentation as one would expect from the tumour sites with the likely blockage of cerebrospinal fluid pathways. The possibility of skull expansion and suture separation may prevent this being a major feature, and Till (1975) showed that headache and vomiting were absent in 28'1;, of his large series, and in three-quarters of these papilloedema was also absent.
The biological and clinical spectrum of tumours occurring in early life is different from adults, with a high proportion of tumours of low-grade malignancy and slow growth rate. Some of the implications for treatment in this spectrum will now be reviewed.
Craniopharyngioma
Though this lesion is of congenital origin, its histology is benign and its growth may be so insidious as to be undetected in life or at least not until middle life. Most commonly, however, it occurs in children and young adults when the common presentation is a visual field defect with small stature, and it is often associated with headache and vomiting. Skull X-ray most commonly shows excavation of the pituitary fossa with characteristic calcification, seen in all but one of the 57 cases studied by Matson & Crigler (1969) . Sometimes the lesions are more extensive and the discrete nature of the tumour at surgery may be blurred by local adhesions or actual brain invasion, especially in older patients. This is probably one reason for the considerable dispute about whether a radical surgical approach is the best treatment.
In young patients it is often possible with modern surgical technique to completely resect the majority of such lesions, but the operation is not without risk and the problems of the long-term management of hypopituitarism in young children are not inconsiderable. The alternative therapy originally suggested by Carpenter et al. (1937) and reported on by Kramer et al. (1961) in more recent years, offers postoperative radiotherapy after aspiration of the cyst fluid and biopsy. Standard dosage in radiotherapy of 5000 rad in seven weeks to a very limited volume is well tolerated. With such an approach, McKissock & Ford (1966) reported 73/~survival in 45 cases (compared with 22/~survival in 55 cases treated by surgery alone) and Bloom (1975) reported 85% five-year survival in 40 cases. Both these series included adults and children. Matson & Crigler (1969) reported 57 childhood cases in which radical surgery was the treatment; 55/~were alive with follow up from 4-19 years. The life history of this lesion is very variable and recurrence as late as 20 years after primary treatment has been recorded.
Optic pathway gliomas
The classification of this lesion as a tumour has been challenged on histological and clinical grounds, but consensus is that it is a glioma of low grade. Its effects on vision and endocrine function may be severe and it may even threaten life. Most often it is an apparently diffuse process of spread longitudinally within the optic tract, or chiasm, or one or both optic nerves. Sometimes, however, it is a discrete lesion within one optic nerve.
Gauthier (1973) , in a series of 51 cases, lists 4 as involving optic nerves only, 17 chiasmal and 30 diffuse lesions. Surgery may be curative in the discrete cases involving one optic nerve. In the diffuse lesions, radiotherapy is often advocated, but its appropriateness in a tumour of such slow growth and low-grade malignancy is questioned. There is no doubt, however, that radiotherapy doses of 5000-5500 rad in seven weeks can achieve objective improvement as judged by decrease in proptosis, arrest of visual deterioration and reduction in tumour bulk, as seen on computerized tomography scan. Olive (1977) described 13 chiasmallesions, 9 of which received irradiation, with dramatic response in 5 cases.
Hypothalamic and third ventricle tumours
Certain of the optic tract gliomas present with the visual field defect a less prominent feature, the clinical picture being rather dominated by features of involvement of the hypothalamus and third ventricle. There may be signs of precocious puberty, diabetes insipidus, the diencephalic syndrome, with or without visual problems, and raised intracranial 'pressure. It is often difficult to distinguish these lesions from other tumours of the site, which are most often gliomas of low grade. In the case of the less common, high-grade malignancy gliomas, presentation may take the form of a rapid progression of endocrine disturbance or of blockage to cerebrospinal fluid pathways, with the necessity of surgical shunting as the first treatment. 5000 rad given in seven weeks may control the slowly growing tumours and pubertal changes may be arrested or reversed. In the series studied by Bloom (1975) , 29 of 32 cases were alive one
year after irradiation and 20 cases out of 26 were alive at five years from treatment.
Brain-stem gliomas
About 12/~of children's brain tumours occur in this area (Bloom 1975 ). Even biopsy is usually inadvisable and the prognosis is poor. Most commonly the histology is of a highly malignant astrocytoma, but the differential diagnosis of encephalitis or a dermoid cyst has to be considered before treatment. All series reveal poor survival in the highly malignant lesions, but radiotherapy can achieve worthwhile clinical improvement of the gross cranial nerve palsies and pyramidal tract signs which are such a common feature. However, recurrence commonly occurs within one year. Only 15 (44%) of Bloom's 34 cases irradiated to doses of 5000 rad in 6~-7 weeks were alive at one year, and 19% at three years (Bloom 1975) .
Cerebellar astrocytomas
This group make up approximately 15';';, of childhood tumours and they are different in behaviour from the common astrocytomas of the cerebral hemisphere in adults. They are most commonly grade I-II and they tend to be discrete and easily separable from the surrounding brain tissue. They are often confined to one cerebellar hemisphere and about 65';;' of them are cystic with a nubbin of tumour in the wall. Their growth may be exceedingly slow, so that at diagnosis they may have formed a large rounded mass with thinning of the occipital bone and severe hydrocephalus. Surgical removal is often complete in which case the chance of survival is good, with a low operative mortality. In the more solid variety, usually of grade II-III malignancy, total excision is not so frequently possible. Radiotherapy is advised in such cases. Bloom (1975) reported 56~;' three-year survival in 23 cases irradiated to 5000 rad in 6t-7 weeks. Where only partial removal of a cystic tumour of low-grade malignancy has been achieved it is still curiously possible to have long-term survivors without apparent new growth of tumour (Till 1975 , Gol & McKissock 1959 .
Medulloblastoma
This tumour has a poor outlook for survival. Its substance tends to merge imperceptibly into the normal brain tissue making a clear line of surgical removal difficult. The involvement of mid-line structures with infiltration of the roof or floor of the fourth ventricle as well as spread upwards and downwards in the brain stem, even to the upper cervical cord, makes total removal impossible in many cases. Such extension at once worsens the prognosis. The operative mortality, in the region of 30'1,; at the time of Cushing (1930) , is still of the order of I O~O (Bloom 1975 , Till 1975 .
There is no doubt about the radioresponsiveness of this tumour, but the risk of local recurrence remains high, as the dose of irradiation required to ensure tumour eradication may be beyond normal tissue tolerance. Spread ofcells within the cerebrospinal fluid giving nodular recurrence along the meninges requires that whole nervous system irradiation be performed. This is a complex technical exercise in which the aim is to give maximum dosage (5000-5500 rad) to the local tumour site including any known areas of extension. The rest of the cranial meninges and the spinal theca down to S2 level receive 3000-3500 rad. There is probably little room for technical improvement in the radiotherapy given and most centres record a three to five year survival figure of approximately 40,/;' in unselected cases (Bloom 1975) .
Chemotherapy in childhood brain tumours Improvement in treatment results, in medulloblastoma in particular, has been sought in the use of cytotoxic drugs. Success in other childhood malignancies using adjuvant chemotherapy has occurred, but many of the drugs do not reach the central nervous system in adequate concentration. Vincristine, CCNU (lomustine), and others of the nitrosourea group, as well as methotrexate intrathecally and in high dose intravenously, have been used with some benefit in recurrent cases. Formal randomized studies are now in progress to assess the effect on survival when chemotherapy is added to the primary treatment in brain tumours (Bloom 1975) .
Much information has been obtained from studies in adult cerebral glioblastomas about the usefulness of various cytotoxic agents. In some cases, temporary remissions are obtained and survival may be prolonged by many weeks. In children's tumours, where there is a wide spectrum of biological behaviour, their role is not established and, as yet, there is little evidence of benefit additional to that obtained by radiotherapy with surgery.
Effects of treatment
In treating these tumours, a balance must be struck between effective treatment and unacceptable morbidity. Surgical and anaesthetic risks have decreased markedly in recent years.
In radiotherapy, every effort is made to avoid the beam's passage through a sighted eye; but a radiation cataract is a relatively small price to pay if the patient's life is at risk. The effect of spinal irradiation on bone growth is not so severe with the current use of supervoltage irradiation as in the orthovoltage era. Radiation dosage to tumour-bearing areas of the central nervous system, however, is chiefly limited by the tolerance of normal tissues, the hypothalamus and brain stem being especially susceptible. Growth hormone deficiency, caused by suppression of hypothalamic function following cranial irradiation, is being studied by many workers, but the severity of the problem is likely to be related to dose and time factors in radiation therapy. Accumulated evidence suggests that actual necrosis of nervous tissue is unlikely to occur at doses of 5000 rad over seven weeks. Giving higher doses, however, or treating more quickly will increase this risk (Lindgren 1958) . Damage to nervous tissue is also being observed with the use of methotrexate.
In the very young child, when myelination of the brain and establishment of synaptic connections may not be complete at least until three years of age, radiation dosage should be modified. It would seem that the brain is more vulnerable to damage of all kinds during this developmental period (Dobbing & Sands 1973) . Clinical assessment of long-term survivors in terms of physical and intellectual development after treatment for medulloblastoma bears this out (Bloom et al. 1969) . In all efforts to improve survival in this group of very damaging tumours, prospective evaluation of these functions must be performed.
